Background The role of interleukins in the pathogenesis of lipodystrophy in HIV/AIDS-
patients is still not understood. The aim of this study was to evaluate the relationship …

Purpose Combined antiretroviral therapy (cART) for the treatment of HIV-1 infection has
been associated with complications, including lipodystrophy. Several interleukins have been …

Lipodystrophy syndrome is a medical condition characterized by the absence of adipose
tissue without any underlying starvation or macromolecule breakdown. In HIV AIDS patients …

Objective: To determine HIV and antiretroviral drug distribution in plasma and fat tissue of
HIV-infected patients with lipodystrophy. Methods: Twenty-three consecutive HIV-infected …

Background: Despite the benefits in improving the clinical state of people living with HIV/aids
(PLWHA), some side effects associated with the use of antiretroviral therapy (ART) are …

Introduction: HIV-positive patient lipodystrophy is the redistribution of body fat and may be
accompanied by cardiovascular and metabolic disorders. Objective: Was to investigate the …

Background. Although the association between lipoatrophy and highly active antiretroviral
therapy (HAART) is well known, other nondrug factors may be associated with lipoatrophy in …

Objective To achieve a better understand of the pathophysiology of HIV-related lipoatrophy,
we compared the mRNA expression of adipocytokines in fat samples from patients and …

Lipodystrophy is a common alteration in HIV 1-infected patients under anti-retroviral
treatment. This syndrome is usually associated with peripheral lipoatrophy, central adiposity …

The extensive use of Highly Active Antiretroviral Therapy (HAART) has transformed HIV
infection into a chronic condition. Thus, metabolic alterations including lipodystrophy and …